VBI Vaccines Inc (VBIV)
0.5858
-0.02
(-3.73%)
USD |
NASDAQ |
Apr 24, 15:02
VBI Vaccines Cash and Short Term Investments (Quarterly): 23.68M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 23.68M |
September 30, 2023 | 35.45M |
June 30, 2023 | 20.84M |
March 31, 2023 | 40.39M |
December 31, 2022 | 62.63M |
September 30, 2022 | 83.55M |
June 30, 2022 | 82.41M |
March 31, 2022 | 101.34M |
December 31, 2021 | 121.69M |
September 30, 2021 | 137.47M |
June 30, 2021 | 135.03M |
March 31, 2021 | 133.56M |
December 31, 2020 | 119.10M |
September 30, 2020 | 120.38M |
June 30, 2020 | 86.07M |
March 31, 2020 | 35.80M |
December 31, 2019 | 44.21M |
September 30, 2019 | 53.02M |
June 30, 2019 | 30.08M |
March 31, 2019 | 43.31M |
December 31, 2018 | 59.27M |
September 30, 2018 | 25.99M |
June 30, 2018 | 41.13M |
March 31, 2018 | 58.09M |
December 31, 2017 | 67.69M |
Date | Value |
---|---|
September 30, 2017 | 10.05M |
June 30, 2017 | 15.64M |
March 31, 2017 | 23.51M |
December 31, 2016 | 32.28M |
September 30, 2016 | 16.72M |
June 30, 2016 | 21.81M |
March 31, 2016 | 10.96M |
December 31, 2015 | 12.48M |
September 30, 2015 | 16.01M |
June 30, 2015 | 37.96M |
March 31, 2015 | 39.43M |
December 31, 2014 | 40.01M |
September 30, 2014 | 35.03M |
June 30, 2014 | 37.54M |
March 31, 2014 | 37.71M |
December 31, 2013 | 40.87M |
September 30, 2013 | 43.94M |
June 30, 2013 | 44.33M |
March 31, 2013 | 48.47M |
December 31, 2012 | 52.98M |
September 30, 2012 | 54.58M |
June 30, 2012 | 55.05M |
March 31, 2012 | 58.19M |
December 31, 2011 | 59.58M |
September 30, 2011 | 61.60M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
20.84M
Minimum
Jun 2023
137.47M
Maximum
Sep 2021
77.20M
Average
82.41M
Median
Jun 2022
Cash and Short Term Investments (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 3.13M |
Palatin Technologies Inc | 9.485M |
iBio Inc | 2.788M |
Theriva Biologics Inc | 23.18M |
Oragenics Inc | 3.484M |